DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$10.27−0.75 (-6.81%)
Close on Nov 16, 2026Market cap $645.76MP/E –Yield –
DBV Technologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
DBV Technologies's revenue for the twelve months ending Sep 30, 2026 was $3.84M, down 31.6% year over year. For fiscal 2025 it was $5.64M, up 35.8% from the year before. The highest annual figure on record is $15.73M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.64M | +35.8% |
| FY2024 | Dec 31, 2024 | $4.15M | -73.6% |
| FY2023 | Dec 31, 2023 | $15.73M | +224.7% |
| FY2022 | Dec 31, 2022 | $4.84M | -15.1% |
| FY2021 | Dec 31, 2021 | $5.71M | -49.4% |
| FY2020 | Dec 31, 2020 | $11.28M | -23.3% |
| FY2019 | Dec 31, 2019 | $14.71M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.60M | -42.9% |
| Q2 FY2026 | Jun 30, 2026 | $700.00K | -53.3% |
| Q1 FY2026 | Mar 31, 2026 | $900.00K | +12.5% |
| Q4 FY2025 | Dec 31, 2025 | $636.00K | +24.5% |
| Q3 FY2025 | Sep 30, 2025 | $2.80M | +161.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.50M | +29.2% |
| Q1 FY2025 | Mar 31, 2025 | $800.00K | -43.1% |
| Q4 FY2024 | Dec 31, 2024 | $511.00K | -94.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.07M | -54.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.16M | -49.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.41M | -35.9% |
| Q4 FY2023 | Dec 31, 2023 | $8.88M | +327.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.37M | +55.1% |
| Q2 FY2023 | Jun 30, 2023 | $2.29M | -10.1% |
| Q1 FY2023 | Mar 31, 2023 | $2.19M | -25.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.07M | +56.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.53M | – |
| Q1 FY2022 | Mar 31, 2022 | $2.55M | -13.4% |
| Q4 FY2021 | Dec 31, 2021 | $2.93M | -29.5% |
| Q3 FY2021 | Sep 30, 2021 | $1.32M | -63.4% |
| Q2 FY2021 | Jun 30, 2021 | -$1.49M | -131.5% |
| Q1 FY2021 | Mar 31, 2021 | $2.94M | – |
| Q3 FY2020 | Sep 30, 2020 | $4.16M | – |
| Q2 FY2020 | Jun 30, 2020 | $3.61M | – |
| Q1 FY2020 | Mar 31, 2020 | $4.72M | – |
See a number that looks wrong?